AtaGenix Laboratories
AtaGenix Laboratories
Release time: 2026-03-23 View volume: 2
Monoclonal and polyclonal antibodies are the two fundamental types of research antibodies. Understanding their differences in production, specificity, batch consistency, and application suitability is essential for choosing the right tool for every experiment.
Monoclonal Antibody (mAb): Produced by a single B cell clone (typically via hybridoma or recombinant expression). Recognizes one specific epitope on the target antigen. Every molecule in every batch is identical.
Polyclonal Antibody (pAb): Produced by multiple B cell clones in an immunized animal. Recognizes multiple epitopes on the same antigen. A mixture of different antibody molecules with varying affinities and specificities.
| Feature | Monoclonal (mAb) | Polyclonal (pAb) |
|---|---|---|
| Epitope Recognition | Single epitope | Multiple epitopes |
| Specificity | Very high (single target site) | Broad (may cross-react with homologs) |
| Batch Consistency | Identical batch-to-batch | Varies between bleeds/animals |
| Signal Strength | Lower (one epitope) | Higher (signal amplification via multiple epitopes) |
| Production Time | ~59 days (hybridoma) or ~45 days (single B cell) | 51–70 days |
| Renewable Supply | Unlimited (cell bank or sequence) | Limited (animal lifespan, serum volume) |
| Cost | Higher upfront, lower long-term | Lower upfront, higher long-term (re-immunization) |
Choose Monoclonal When:
You need high specificity for a single epitope, reproducible results across labs and over time, long-term renewable supply, quantitative assays (ELISA, FC), diagnostic kit development, or therapeutic antibody candidates.
Choose Polyclonal When:
You need strong signal for low-abundance targets (WB, IHC), detection of denatured or partially degraded proteins, fast turnaround for preliminary experiments, immunogen validation before investing in monoclonal development, or secondary antibody production.
Yes, this is a common and cost-effective strategy. Start with a polyclonal antibody to validate the target and antigen design quickly. Once confirmed, proceed with monoclonal development (hybridoma or single B cell) for reproducible, long-term supply. AtaGenix supports both pAb and mAb workflows and can use the same immunized animals to transition from polyclonal serum collection to monoclonal clone screening.
Need help deciding between monoclonal and polyclonal for your project? AtaGenix provides both custom pAb (51–70 days) and mAb development (hybridoma, single B cell, phage display) with full application validation.
Talk to Technical SupportResponse within 24 hours
Contact Us
+86-27-87001869
info@atagenix.com
Building C, R & D Building, No. 666, Shendun 4th Road, Donghu New Technology Development Zone, Wuhan
